Cargando…

Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2

The current SARS-CoV-2 pandemic forms a major global health burden. Although protective vaccines are available, concerns remain as new virus variants continue to appear. CRISPR-based gene-editing approaches offer an attractive therapeutic strategy as the CRISPR-RNA (crRNA) can be adjusted rapidly to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussein, Mouraya, Andrade dos Ramos, Zaria, Vink, Monique A., Kroon, Pascal, Yu, Zhenghao, Enjuanes, Luis, Zuñiga, Sonia, Berkhout, Ben, Herrera-Carrillo, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051389/ https://www.ncbi.nlm.nih.gov/pubmed/36992394 http://dx.doi.org/10.3390/v15030686

Ejemplares similares

In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack
por: Hussein, Mouraya, et al.
Publicado: (2022)

A CRISPR-Cas Cure for HIV/AIDS
por: Hussein, Mouraya, et al.
Publicado: (2023)

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
por: Darcis, Gilles, et al.
Publicado: (2019)

A combinatorial CRISPR-Cas12a attack on HIV DNA
por: Fan, Minghui, et al.
Publicado: (2022)

CRISPR/Cas9: a double-edged sword when used to combat HIV infection
por: Liang, Chen, et al.
Publicado: (2016)

A Single H1 Promoter Can Drive Both Guide RNA and Endonuclease Expression in the CRISPR-Cas9 System
por: Gao, Zongliang, et al.
Publicado: (2018)

Harnessing the CRISPR-Cas Systems to Combat Antimicrobial Resistance
por: Duan, Cheng, et al.
Publicado: (2021)

Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA
por: Gao, Zongliang, et al.
Publicado: (2020)

The Impact of CRISPR-Cas System on Antiviral Therapy
por: Bayat, Hadi, et al.
Publicado: (2018)

The Application of CRISPR/Cas Systems for Antiviral Therapy
por: Baddeley, Helen J. E., et al.
Publicado: (2021)

How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance
por: Gholizadeh, Pourya, et al.
Publicado: (2020)

Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
por: Chan, Kok Gan, et al.
Publicado: (2021)

In-house ELISA protocols for capsid p24 detection of diverse HIV isolates
por: Molina, Mariano A., et al.
Publicado: (2023)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
por: Chen, Shuliang, et al.
Publicado: (2018)

Elimination of infectious HIV DNA by CRISPR–Cas9
por: Das, Atze T, et al.
Publicado: (2019)

MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity
por: Wang, Li, et al.
Publicado: (2021)

CRISPR/Cas9: A Novel Weapon in the Arsenal to Combat Plant Diseases
por: Das, Ayan, et al.
Publicado: (2019)

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
por: Abbott, Timothy R., et al.
Publicado: (2020)

Improvement of the CRISPR-Cpf1 system with ribozyme-processed crRNA
por: Gao, Zongliang, et al.
Publicado: (2018)

Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens
por: Khambhati, Khushal, et al.
Publicado: (2022)

CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
por: Javed, Muhammad Uzair, et al.
Publicado: (2023)

CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector
por: Siegrist, Cathryn M., et al.
Publicado: (2020)

CRISPR-Cas system: from diagnostic tool to potential antiviral treatment
por: Rajan, Aishwarya, et al.
Publicado: (2022)

Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles
por: Wan, Fen, et al.
Publicado: (2021)

Towards Antiviral shRNAs Based on the AgoshRNA Design
por: Liu, Ying Poi, et al.
Publicado: (2015)

CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance
por: Mayorga-Ramos, Arianna, et al.
Publicado: (2023)

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
por: Lee, Choongho
Publicado: (2019)

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems
por: Brezgin, Sergey, et al.
Publicado: (2021)

COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19
por: Zhan, Yan, et al.
Publicado: (2021)

Single cell variability of CRISPR‐Cas interference and adaptation
por: McKenzie, Rebecca E, et al.
Publicado: (2022)

An Ethical Overview of the CRISPR-Based Elimination of Anopheles gambiae to Combat Malaria
por: Wise, India Jane, et al.
Publicado: (2022)

Use of Bacteriophage Amended with CRISPR-Cas Systems to Combat Antimicrobial Resistance in the Bacterial Foodborne Pathogen Listeria monocytogenes
por: Parsons, Cameron, et al.
Publicado: (2021)

CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
por: Wang, Gang, et al.
Publicado: (2016)

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
por: Deans, Richard M., et al.
Publicado: (2016)

CRISPR-Cas13d Exhibits Robust Antiviral Activity Against Seneca Valley Virus
por: Zhang, Yu-Yuan, et al.
Publicado: (2022)

PAM-repeat associations and spacer selection preferences in single and co-occurring CRISPR-Cas systems
por: Vink, Jochem N. A., et al.
Publicado: (2021)

CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA
por: Binda, Caroline S., et al.
Publicado: (2020)

Crispr/Cas9 Mediated Inactivation of Argonaute 2 Reveals its Differential Involvement in Antiviral Responses
por: Ludman, Márta, et al.
Publicado: (2017)

CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
por: Amini, Leila, et al.
Publicado: (2021)

Construction of Baculovirus-Inducible CRISPR/Cas9 Antiviral System Targeting BmNPV in Bombyx mori
por: Liu, Yujia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u0084qk7cv1amgtsmjdskr8rqu